{"title":"The Concept of Treatment-Refractory Addiction: A Call to the Field.","authors":"Eric C Strain","doi":"10.1097/ADM.0000000000001349","DOIUrl":null,"url":null,"abstract":"<p><strong>Abstract: </strong>Not all patients respond to effective and approved treatment interventions, and there has been growing recognition in the medical field of these \"resistant\" or refractory illnesses (eg, treatment-resistant depression, resistant hypertension). In the field of substance use disorders, there has not been an explicit acknowledgement of treatment-refractory addiction (TRA) despite substantial evidence that many patients do not respond to standard-of-care treatment interventions. This article provides a justification for TRA as a critically important condition to recognize and define. TRA is not conceptualized as a diagnosis, but as a signal that a current treatment approach has not worked. The article addresses areas in need of research and consensus in order to ensure the approach to TRA is uniform, thoughtfully addressed, and data-driven. By explicitly acknowledging TRA, clinicians, researchers, and patients and their families can begin to explore the unique features of this population and find ways in which substance use disorders for persons with TRA can be more effectively addressed, which in turn will help to expand remission for persons who suffer from these devastating conditions.</p>","PeriodicalId":14744,"journal":{"name":"Journal of Addiction Medicine","volume":"18 5","pages":"474-476"},"PeriodicalIF":4.2000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Addiction Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/ADM.0000000000001349","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/10 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
引用次数: 0
Abstract
Abstract: Not all patients respond to effective and approved treatment interventions, and there has been growing recognition in the medical field of these "resistant" or refractory illnesses (eg, treatment-resistant depression, resistant hypertension). In the field of substance use disorders, there has not been an explicit acknowledgement of treatment-refractory addiction (TRA) despite substantial evidence that many patients do not respond to standard-of-care treatment interventions. This article provides a justification for TRA as a critically important condition to recognize and define. TRA is not conceptualized as a diagnosis, but as a signal that a current treatment approach has not worked. The article addresses areas in need of research and consensus in order to ensure the approach to TRA is uniform, thoughtfully addressed, and data-driven. By explicitly acknowledging TRA, clinicians, researchers, and patients and their families can begin to explore the unique features of this population and find ways in which substance use disorders for persons with TRA can be more effectively addressed, which in turn will help to expand remission for persons who suffer from these devastating conditions.
摘要:并不是所有患者都对有效和经批准的治疗干预措施有反应,医学界对这些 "抵抗性 "或难治性疾病(如治疗抵抗性抑郁症、抵抗性高血压)的认识也在不断提高。在药物使用障碍领域,尽管有大量证据表明许多患者对标准治疗干预措施没有反应,但治疗难治性成瘾(TRA)尚未得到明确承认。本文为 TRA 提供了正当理由,认为 TRA 是一种需要认识和定义的极其重要的病症。TRA 并不是一种诊断,而是当前治疗方法无效的信号。文章探讨了需要研究和达成共识的领域,以确保治疗 TRA 的方法是统一的、经过深思熟虑的和以数据为导向的。通过明确承认 TRA,临床医生、研究人员和患者及其家属可以开始探索这一人群的独特特征,并找到可以更有效地解决 TRA 患者药物使用障碍的方法,这反过来将有助于扩大这些毁灭性疾病患者的缓解范围。
期刊介绍:
The mission of Journal of Addiction Medicine, the official peer-reviewed journal of the American Society of Addiction Medicine, is to promote excellence in the practice of addiction medicine and in clinical research as well as to support Addiction Medicine as a mainstream medical sub-specialty.
Under the guidance of an esteemed Editorial Board, peer-reviewed articles published in the Journal focus on developments in addiction medicine as well as on treatment innovations and ethical, economic, forensic, and social topics including:
•addiction and substance use in pregnancy
•adolescent addiction and at-risk use
•the drug-exposed neonate
•pharmacology
•all psychoactive substances relevant to addiction, including alcohol, nicotine, caffeine, marijuana, opioids, stimulants and other prescription and illicit substances
•diagnosis
•neuroimaging techniques
•treatment of special populations
•treatment, early intervention and prevention of alcohol and drug use disorders
•methodological issues in addiction research
•pain and addiction, prescription drug use disorder
•co-occurring addiction, medical and psychiatric disorders
•pathological gambling disorder, sexual and other behavioral addictions
•pathophysiology of addiction
•behavioral and pharmacological treatments
•issues in graduate medical education
•recovery
•health services delivery
•ethical, legal and liability issues in addiction medicine practice
•drug testing
•self- and mutual-help.